Instructions for Study Teams - TREMENDOUS

March 2026

Instructions for principal investigators and study teams when submitting a new application or change in research to offer study participants payment/reimbursement via TREMENDOUS

These instructions are intended for study teams utilizing TREMENDOUS for participant payment.

This step by step instruction guide details how to document the planned use of TREMENDOUS in your eIRB application as part of a New Application or Change in Research.

The instructions below detail requirements that are specific to use of TREMENDOUS. Please follow the step by step instructions listed below:

For New Applications

  • If your study will use written consent, then in section 15 (Written Consent) item 1, please add the following sentence “This study will offer participants a choice to receive payment/reimbursement through TREMENDOUS Program. The standard TREMENDOUS information sheet will be used to explain the use of TREMENDOUS to participants.”
  • If your study will use a waiver of documentation (oral consent), then in section 16 (Waiver of Documentation of Consent) item 1, please add the following sentence “This study will offer participants a choice to receive payment/reimbursement through TREMENDOUS Program. The standard TREMENDOUS information sheet will be used to explain the use of TREMENDOUS to participants.”

If your study will use multiple consent methods mentioned above, please add the sentence in each section.

For Changes in Research

  • In section 1 (General Information) item 1 of the Change in Research, please select the box next to “Other”.
  • In section 1 (General Information) item 3, please state “This Change in Research adds payment through TREMENDOUS Program as a payment option for participants.”
  • If your study will use written consent, then in section 15 (Written Consent) item 1, please add the following sentence “This study will offer participants a choice to receive payment/reimbursement through JHU TREMENDOUS Program. The standard TREMENDOUS information sheet will be used to explain the use of TREMENDOUS to participants.”
  • If your study will use a waiver of documentation (oral consent), then in section 16 (Waiver of Documentation of Consent) item 1, please add the following sentence “This study will offer participants a choice to receive payment/reimbursement through TREMENDOUS Program. The standard TREMENDOUS information sheet will be used to explain the use of TREMENDOUS to participants.” 

If your study was approved for multiple consent methods mentioned above, please add the sentence in each section.